John L. Marshall, MD, to Participate in the White House Cancer Moonshot Colorectal Cancer Forum
On Friday, March 10th, from 3:00- 5:30 pm, John L. Marshall, MD, will participate in the White House Cancer Moonshot Colorectal Cancer Forum, an important event providing an opportunity for our community members to make their voices heard.
The occasion will feature discussions among experts and those directly impacted by cancer, including patients, caretakers, oncologists, researchers, and administration officials. The focus will be on progress and opportunities in colorectal cancer awareness, screening, access, and treatments.
Dr. John L. Marshall is the Physician Executive Director at MedStar Washington DC Integrated Hematology Oncology Division, Director of The Ruesch Center for the Cure of Gastrointestinal Cancers, Frederick P. Smith Endowed Chair, Chief Medical Officer at Lombardi Comprehensive Cancer Center, Georgetown University Medical Center. Dr. John L. Marshall is an internationally recognized expert in new drug development for GI cancer, specializing in phase I, II, and III trial design. He has served as Principal Investigator for more than one hundred clinical trials throughout his career. While he has an interest in many areas of cancer research, his primary focus is on the use of precision medicine to treat cancer. Dr. Marshall has become an outspoken advocate for GI cancer patients and the importance of clinical research participation. In 2009, he established the Otto J Ruesch Center for the Cure of GI Cancers, an organization solely focused on improving the lives of GI cancer patients through innovative research, personalized medicine, and focused advocacy.
“In 2016, as Vice President, Joe Biden led the Cancer Moonshot to accelerate the progress against cancer, uniting the cancer advocacy, patient health care, and research community. As President, he has reignited this program with the goal of cutting the death rate from cancer by at least 50% over the next 25 years and improving the experience of people impacted by cancer.” The White House. In 2018 the Ruesch Center was pleased to honor then Vice President Biden with a Luminary Award in GI Cancers for his tremendous cancer advocacy efforts.
Discussants include expert GI Cancer advocates and Ruesch research collaborators Cathy Eng, MD, Professor of Medicine, Hematology-Oncology, and Co-Director of GI Oncology, Co-Leader of the Gastrointestinal Cancer, Research Program, Vanderbilt-Ingram Cancer Center; Nilo Azad, MD, National Cancer Advisory Board & Professor of Oncology and Co-Director of Cancer Genetics and Epigenetics, Johns Hopkins University; Anjee Davis, President, Fight Colorectal Cancer; Michael Sapienza, Chief Executive Officer, Colorectal Cancer Alliance and Phuong Gallagher, President, Colon Club, Colorectal Cancer Survivor.
“We are pleased that CRC is getting this much-needed attention and support. We can solve this major medical problem if we work together!” said John L . Marshall, MD.
Tune into the event starting at 3:00 pm ET on Friday, March 10, 2023.